Intraprostatic BCG vaccine in patients with prostatic cancer, expression of interferon γ and interleukin 4;Vacuna BCG intraprostítica en pacientes con cáncer de próstata. Expresión de gamma interferón e interleukina 4. (Aportación preliminar)

Actas Urologicas Espanolas

Volumn 26, Issue 5, 2002, Pages 351-355

  Rivera, G P ^b   Inostroza, S J ^a,b   Treulen F ^b  

^a Hospital Regional Temuco   (Spain)

^b UNIVERSIDAD DE LA FRONTERA   (Chile)

Author keywords

BCG vaccine; Immunotherapy; Prostatic cancer

Indexed keywords

BCG VACCINE; GAMMA INTERFERON; INTERLEUKIN 4; MESSENGER RNA;

ANTINEOPLASTIC ACTIVITY; ARTICLE; B LYMPHOCYTE; BCG VACCINATION; BLADDER CANCER; CANCER IMMUNOTHERAPY; CANCER STAGING; CASE REPORT; CELL COUNT; CYTOKINE PRODUCTION; CYTOTOXIC T LYMPHOCYTE; HELPER CELL; HUMAN; MALE; NATURAL KILLER CELL; PROSTATE CANCER; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; BIOPSY; COMPARATIVE STUDY; GENETICS; IMMUNOLOGY; MACROPHAGE; PATHOLOGY; PROSTATE; PROSTATE TUMOR;

BCG VACCINE; BIOPSY; HUMANS; INTERFERON TYPE II; INTERLEUKIN-4; KILLER CELLS, NATURAL; MACROPHAGES; MALE; PROSTATE; PROSTATIC NEOPLASMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; T-LYMPHOCYTES, CYTOTOXIC;

EID: 0036303919     PISSN: 02104806     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0210-4806(02)72789-7     Document Type: Article

References (18)

1. Intracavitary bacillus Calmette-Guerin in the treatment of superficial bladder tumor
2. Tratamiento del cáncer de la vejiga: Instilación de microdosis de vacuna BCG
3. Microdosis de vacuna BCG como profilaxis en cáncer vesical etapa T1
4. Profilaxis del cáncer vesical superficial con 1 mg de BCG endovesical, comparación con otras dosis
5. Respuesta de linfocitos y citokinas en pacientes portadores de cáncer vesical superficial, tratados con instilaciones de 1 mg de vacuna BCG
6. Fibronectin mediated Calmette-Guerin Bacillus attachment to murine bladder mucosa. Refuirement of the expression of an antitumor response
7. Non-specific, rapidly generated cytotoxicity in lymphocytes induced by BCG in vitro: No evidence of enhancing effect from preceding interaction between BCG and transitional cell line cells
8. Maintenance BCG immunotherapy: Evidence of additional protection against cancer. A southwest oncology group study
9. The antimetastatic effect of IV-inoculated BCG on adenocarcinomas in the prostate-seminal vesicle complex of LW rats
10. Induction of controlled prostatic tissue necrosis by BCG derivatives
11. The role of cytokines in autoimmunity
12. Cytokine production by human cells in disease states
13. Intravesical BCG therapy for in situ transitional cell carcinoma involving the prostatic urethra
14. The anti-metastatic effect of intravenously-inoculated BCG on prostate tumor cells
15. Immunotherapy by BCG against prostate adenocarcinoma in anatomical compartments